35%, p < 10 −100 ), among other relevant genes, showed highly significant increased expression at follow‐up (Figure 3B ). 4.
← all excerpts
A Case-Driven Multi-Omics Analysis for Longitudinal Ibrutinib Response Evaluation of Patients With Chronic Lymphocytic Leukemia.
1
—
—